Background/Objectives: The rapid emergence of multidrug-resistant bacterial infections demands innovative non-antibiotic therapeutic strategies. Dual-modal photoresponse therapy integrating photodynamic (PDT) and photothermal (PTT) effects offers a promising rapid antibacterial approach, yet designing single-material systems with synergistic enhancement remains challenging. This study aims to develop uniform Cu-based metal–organic framework micrometer cubes (Cu-BN) for efficient PDT/PTT synergy. Methods: Cu-BN cubes were synthesized via a one-step hydrothermal method using Cu(NO3)2 and 2-amino-p-benzoic acid. The material’s dual-mode responsiveness to visible light (420 nm) and near-infrared light (808 nm) was characterized through UV–Vis spectroscopy, photothermal profiling, and reactive oxygen species (ROS) generation assays. Antibacterial efficacy against multidrug-resistant Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) was quantified via colony counting under dual-light irradiation. Results: Under synergistic 420 + 808 nm irradiation for 15 min, Cu-BN (200 μg/mL) achieved rapid eradication of multidrug-resistant E. coli (99.94%) and S. aureus (99.83%). The material reached 58.6 °C under dual-light exposure, significantly exceeding single-light performance. Photodynamic analysis confirmed a 78.7% singlet oxygen (1O2) conversion rate. This enhancement stems from PTT-induced membrane permeabilization accelerating ROS diffusion, while PDT-generated ROS sensitized bacteria to thermal damage. Conclusions: This integrated design enables spatiotemporal PDT/PTT synergy within a single Cu-BN system, establishing a new paradigm for rapid-acting, broad-spectrum non-antibiotic antimicrobials. The work provides critical insights for developing light-responsive biomaterials against drug-resistant infections.
Background/Objectives: The rapid emergence of multidrug-resistant (MDR) bacteria has increased the demand for non-antibiotic antibacterial strategies. Although photothermal therapy (PTT) and photodynamic therapy (PDT) are promising alternatives, each modality alone may show limited antibacterial efficacy. This study aimed to construct a flexible dual-light-responsive nanofibrous membrane integrating PTT and PDT for improved in vitro antibacterial activity against MDR bacteria. Methods: A silica nanofibrous membrane (SNF) was prepared by electrospinning followed by calcination. An Fe-doped sulfonated TpPa covalent organic framework (SCOF-Fe) was then grown in situ on the SNF surface via an interfacial diffusion strategy to obtain SNF@SCOF-Fe. The membrane was characterized in terms of morphology, structure, optical absorption, photothermal performance, Fe loading, Fe leaching, and reactive oxygen species (ROS) generation. In vitro antibacterial activity against supplier-reported MDR Escherichia coli (E. coli) and methicillin-resistant Staphylococcus aureus (MRSA) was evaluated under 420 nm, 808 nm, and dual-light (420 + 808 nm) irradiation. Results: Fe doping broadened the optical absorption of the COF-functionalized membrane into the near-infrared region and improved its photothermal response. Under dual-light irradiation, SNF@SCOF-Fe generated singlet oxygen, superoxide radicals, and hydroxyl radicals, together with a greater temperature increase than the undoped membrane. Within 15 min, SNF@SCOF-Fe achieved antibacterial rates of 99.29% against E. coli and 99.62% against MRSA. In addition, controlled dual-light cytocompatibility testing yielded 78.76% viability in L929 fibroblasts and 82.86% viability in MC38 murine colon carcinoma cells after SNF@SCOF-Fe treatment. Conclusions: SNF@SCOF-Fe combines dual-light-triggered photothermal heating and ROS generation within a flexible nanofibrous membrane and demonstrated effective in vitro antibacterial activity against two representative resistant bacteria. These findings support further investigation of SNF@SCOF-Fe as a light-responsive antibacterial membrane in relevant in vitro and in vivo models.